Refine by
Prostate Test Equipment & Supplies In Australia
11 equipment items found
Manufactured by:Nanostics Inc. based inEdmonton, ALBERTA (CANADA)
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 patient clinical study designed to meet regulatory ...
Manufactured by:LG Chem, Ltd. based inSeoul, SOUTH KOREA
Intended Use: A reagent for in vitro diagnostic devices that qualitatively detect, simultaneously or individually, Chlamydia trachomatis and Neisseria gonorrhoeae present in vaginal discharge, urine, pus, and prostatic fluid using PCR test. System: SLAN-96P - Device used to amplify a specific gene (DNA) for diagnosis of ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The company’s proprietary miR Disease Management Platform® was developed to revolutionize the standard of value-based care for cancers and initially focuses on urological cancers. The initial test delivered by the miR Disease Management Platform® is the miR Sentinel™ Prostate Cancer Test, the first and only standalone, ...
by:RaySearch Laboratories based inStockholm, SWEDEN
Design and optimization of single- or multiple-arc plans is enabled. VMAT planning is done using an optimization procedure (inverse planning). Objectives and constraints for the desired dose are defined and the system creates a plan that matches these criteria as closely as possible within the limitations of the treatment machine. The optimized plan is directly deliverable, without the need for ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
The 4Kscore® Test is used by health care professionals to improve the accuracy of prostate cancer diagnosis after an abnormal prostate-specific antigen (PSA) test result, or digital rectal exam, before the decision is made to biopsy. The 4Kscore® Test provides a risk score (4KScore) for finding aggressive ...
by:Numares GROUP Corp based inRegensburg, GERMANY
Cancer can occur in any organ and in any cell type and the variability in clinical presentation makes early diagnosis difficult. Common cancers with established benefit of early diagnosis but for which there are no sensitive or specific tests are prostate, bladder and liver cancer1. Expensive imaging procedures are routinely required in clinical practice for ...
Manufactured by:UroLift System based inPleasanton, CALIFORNIA (USA)
UroLift Implant: the obstructing prostatic lobes are held apart by small permanent UroLift Implants that are deployed by the delivery device. Each implant is made with common implantable materials: nitinol, stainless steel, and PET suture. Typically, four implants are placed into the ...
Manufactured by:Gaumard Scientific Company, Inc. based inMiami, FLORIDA (USA)
The Advanced ZACK™ Multipurpose Men's Healthcare Task Trainer is a full-sized, lifelike lower torso designed to help students and professionals learn and practice various men's health clinical procedures. The S230.200 has features that facilitate the hands-on acquisition of intimate clinical examination skills, including catheterization, testicular and prostate examination, vasectomy, and ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The science behind miR’s prostate and bladder cancer detection and classification technology that can help give healthcare providers, patients, and payors the greatest confidence in test results and care ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. “Rule-out” otherwise cancer-free men from undergoing unnecessary ...